MedPath

Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

Phase 2
Completed
Conditions
Head and Neck Cancer
Registration Number
NCT00168116
Lead Sponsor
AHS Cancer Control Alberta
Brief Summary

The purpose of this study is to compare the side effects of radiation treatment and surgery versus radiation alone, where no surgery is done to move the salivary gland and place it under the chin region where it can be shielded from radiation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Patients with a histological diagnosis of squamous cell carcinoma
  • Patients with unilateral or no neck involvement of the nasopharynx
  • The submandibular transfer will be done on the uninvolved side of the neck.
  • Karnofsky score greater than or equal to 70
  • Expected survival greater than one year
  • A signed informed consent
Exclusion Criteria
  • Bilateral neck nodes involvement. Involvement of level 1 lymph nodes on the side of the proposed procedure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Quality of life
Secondary Outcome Measures
NameTimeMethod
Complications
Incidence of oral candidiasis
Overall survival
Disease free survival
Pattern of recurrence
Treatment interruptions
Incidence of percutaneous endoscopic gastronomy (PEG)

Trial Locations

Locations (1)

Cross Cancer Institute

🇨🇦

Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath